Year-End Termination

THE LOEFFLER GROUP for CANCER THERAPY AND RESEARCH CENTER

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

DOD Appropriations (HGW 103, SG 103); Drug Discount (HR 2606); Breast Cancer Environmental Research Act (S. 579). HR 1157); Breast Cancer Petient Protection Act (S. 549, HR 758)

LobbyistCovered position, as disclosed
ROBERT H FINNEY N/A
MARGARET HESSION N/A
THOMAS G LOEFFLER N/A
LANE M LUSKEY N/A
JOSE E MARTINEZ N/A
TRAVIS LEE RICHMOND LEGSILATIVE AIDE, SEN. KAY BAILEY HUTCHISON
HANS C RICKHOFF N/A
TIMOTHY N TUGGEY N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1157 (110th), S. 549 (110th), H.R. 758 (110th), S. 579 (110th), H.R. 2606 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.